Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,262 | -41,843 | -29,491 | -35,709 | -28,302 |
| Depreciation Amortization | 266 | 389 | 381 | 638 | 374 |
| Accounts payable and accrued liabilities | -1,412 | 1,605 | -263 | 1 | -209 |
| Other Working Capital | -5,130 | 1,613 | -2,677 | 868 | -613 |
| Other Operating Activity | 5,718 | 5,209 | 4,693 | 3,130 | 2,793 |
| Operating Cash Flow | $-26,820 | $-33,027 | $-27,357 | $-31,072 | $-25,957 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -435 | -170 | -562 | -135 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 38 |
| Investing Cash Flow | $N/A | $-435 | $-170 | $-562 | $-97 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 15,000 |
| Debt Repayment | -6,426 | -4,398 | N/A | -4,739 | N/A |
| Common Stock Issued | 10,685 | 28,898 | 35,602 | 8,861 | 33,533 |
| Other Financing Activity | 0 | 0 | 0 | 7,281 | 10,530 |
| Financing Cash Flow | $4,259 | $24,500 | $35,602 | $11,403 | $59,063 |
| Beginning Cash Position | 30,711 | 39,673 | 31,598 | 51,829 | 18,820 |
| End Cash Position | 8,150 | 30,711 | 39,673 | 31,598 | 51,829 |
| Net Cash Flow | $-22,561 | $-8,962 | $8,075 | $-20,231 | $33,009 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,820 | -33,027 | -27,357 | -31,072 | -25,957 |
| Capital Expenditure | N/A | -435 | -170 | -562 | -135 |
| Free Cash Flow | -26,820 | -33,462 | -27,527 | -31,634 | -26,092 |